Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Adaptive Biotechnologies Corp (NASDAQ: ADPT) was $8.10 for the day, down -1.94% from the previous closing price of $8.26. In other words, the price has decreased by -$1.94 from its previous closing price. On the day, 1.27 million shares were traded.
Ratios:
Our analysis of ADPT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.81 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.44 whereas as Long-Term Debt/Eq ratio is at 0.39.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 19 ’25 when ROBINS CHAD M sold 186,080 shares for $8.46 per share. The transaction valued at 1,574,237 led to the insider holds 2,576,701 shares of the business.
ROBINS CHAD M sold 99,107 shares of ADPT for $836,463 on Feb 20 ’25. The CEO and Chairman now owns 2,576,701 shares after completing the transaction at $8.44 per share. On Feb 20 ’25, another insider, Chad Robins, who serves as the Officer of the company, bought 99,107 shares for $8.37 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.68 while its Price-to-Book (P/B) ratio in mrq is 5.91.
Stock Price History:
Over the past 52 weeks, ADPT has reached a high of $8.95, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is 9.81%, while the 200-Day Moving Average is calculated to be 54.32%.
Shares Statistics:
A total of 147.77M shares are outstanding, with a floating share count of 142.73M. Insiders hold about 3.28% of the company’s shares, while institutions hold 93.23% stake in the company.
